What AHI reduction did SURMOUNT-OSA report, and from which baseline?

I have three data points across nine months, which I hope is enough to see a trend.

I have the document in front of me and I can read the numbers. What I cannot do is interpret them.

I am reasonably comfortable with statistics and completely uncomfortable with chromatography, or vice versa.

What does this actually establish, and what does it not?

Start with the severity band. Mild, moderate and severe obstructive sleep apnoea are defined by AHI thresholds, and moving between bands is the clinically meaningful change.

AHI bands are conventionally five to fifteen for mild, fifteen to thirty for moderate and above thirty for severe. A fall from forty-five to eighteen is a two-band move and still leaves moderate disease.

The underlying point is that daytime somnolence scores improve alongside AHI in these trials, but they also improve with placebo, which is why the instrumented endpoint is the one that carries the argument.

Adherence to positive airway pressure is the main confounder in any real-world comparison and is rarely measured well outside a trial.

This is one of the few places where the instrumented evidence in this class is unusually clean. Use it.

edited 8 Dec 2025 by tare_and_weigh — corrected a unit error in the worked example

Answering this needs to distinguish obstructive from central apnoea, because the mechanism and the expected response differ entirely.

Home sleep apnoea tests systematically underestimate AHI relative to laboratory polysomnography, so a before-and-after comparison should use the same modality or the difference is partly instrumental.

The part that matters: central apnoeas are counted in the same index but arise from respiratory control rather than airway collapse, and there is no reason to expect a weight-mediated intervention to address them.

Nothing here is medical advice. Untreated sleep apnoea carries cardiovascular and accident risk that a forum is not equipped to weigh.

Get a baseline study before you need a comparison, because you cannot obtain one retrospectively.

The mechanism is largely weight-mediated: reducing upper-airway and abdominal adiposity reduces collapsibility and improves respiratory drive mechanics. That makes the effect real and not specific.

Positional dependence matters: an index averaged across the night conceals whether the events are concentrated supine, which changes what a partial improvement is worth.

Apnoea–hypopnoea index thresholds and the scoring rules for hypopnoea have changed more than once, so trials using different scoring criteria report systematically different numbers.

Compare like with like: same modality, same scoring rules, or the difference is partly an artefact.

A sleep study before and after is the only way to answer this for an individual, and the before half is the one people skip.

Oxygen desaturation index and time below ninety per cent saturation are secondary measures that often move further than AHI, because they weight the severe events rather than counting all events equally.

Weight loss by any means is long-established as reducing AHI; the surgical literature has shown this for decades, which is the reason the pharmacological result was expected rather than surprising.

Cite the polysomnography endpoint, not the sleepiness questionnaire.